1 / 14

Commercialization of Research

Commercialization of Research. Genome Canada September 27 th 2011 David T. Dennis Crops of the Future. Time to Market. Takes - 8 to 10 years to commercialize Need patient investors High risk investment Usually need to be close to market . Arabidopsis – the little weed.

katy
Download Presentation

Commercialization of Research

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Commercialization of Research Genome Canada September 27th 2011 David T. Dennis Crops of the Future

  2. Time to Market • Takes - 8 to 10 years to commercialize • Need patient investors • High risk investment • Usually need to be close to market

  3. Arabidopsis – the little weed

  4. Enhanced Breeding Using MutagensUsing Arabidopsis – the little weed

  5. A Drought Tolerant Mutant of the Little Weed 7 days of drought Parent era1

  6. Arabidopsis – the little weed • What is the market for little weeds? • Come back when you have a real product • Real crops have already been highly bred • May not get the Arabidopsis effect • For example: the Green Revolution Gene

  7. Targeting Products Don’t tell me about starving children Starving children have no money

  8. Real Ag-Products • Corn, Soybeans and Cotton • Canola? Rice? • What do you need to market these crops? • Multiple independent homozygous lines • Field trials in multiple locations • Field trials on several years • No effect on yield • Go through the regulatory process

  9. Must Aim at World Markets • Ontario corn is 2% of US corn belt • Offered small investment for exclusive rights to our technology in Ontario corn • You cannot ignore 98% of N. America market • Your technology must have universal appeal

  10. Place of Canada in the World • Coronation Street!!! • The story of dysfunctional people in Manchester • Removal of people from the soap - Canada • Chicago • Investors like to be near their money • Canada is a long way away

  11. Size is Important • Monsanto R&D budget is $1.2 billion • Average Canadian biotech company less than 1% of Monsanto’s • However – we are trying to do the same development programme

  12. Government Money • NSERC Granting Agency • University researcher should do basic research • Move there away from basic research • Inadequately funded • Best government money is R&D tax credits • Other Money • Too difficult to get for a small company • Too directed • Has often to be matched by another company

  13. Management of Biotech Company • Difficult – Still complex research • Don’t let scientists BS you • CEO must be a scientist to prevent this • Also need an effective COO

  14. The Anti – GMO Movement • This has been a massive problem for investment in ag-biotech • Investors do not like uncertainty • People like David Suzuki have great influence • Europe is still a problem

More Related